What is the appropriate acute management for a patient with atrial flutter with rapid ventricular response, third-degree atrioventricular block, and ST‑segment deviation?

Immediate Synchronized Electrical Cardioversion is Required

This patient requires immediate synchronized electrical cardioversion without delay. The combination of atrial flutter with rapid ventricular response (RVR), third-degree AV block, and ST-segment deviation represents a life-threatening emergency with hemodynamic instability and ongoing myocardial ischemia.

Critical Clinical Context

This presentation is paradoxical and extremely rare—the simultaneous occurrence of atrial flutter (requiring intact AV conduction for RVR) and complete heart block appears contradictory. However, this can occur when:

• Variable AV conduction exists with intermittent complete block
• Accessory pathway conduction is present (pre-excitation)
• Acute myocardial ischemia/infarction is causing both arrhythmias simultaneously

The ST-segment deviation indicates ongoing myocardial ischemia or injury, making this a medical emergency requiring immediate intervention.

Immediate Management Algorithm

Step 1: Emergent Cardioversion (Class I Recommendation)

Synchronized cardioversion is mandated immediately 1:

• Initial energy: 50-100 J for atrial flutter (monophasic shock of 50 J for flutter) 2
• Perform under brief general anesthesia or conscious sedation if time permits
• Do NOT delay for anticoagulation in hemodynamically unstable patients 1

The guidelines are unequivocal: "Cardioversion is recommended when a rapid ventricular response to AF or atrial flutter does not respond promptly to pharmacological therapies and contributes to ongoing myocardial ischemia, hypotension, or HF" 1.

Step 2: Concurrent Anticoagulation

Initiate anticoagulation immediately (intravenous heparin, LMWH, or direct thrombin inhibitor) even as cardioversion is being performed 1:

• Administer IV heparin bolus followed by continuous infusion
• Continue anticoagulation for at least 4 weeks post-cardioversion
• Long-term anticoagulation based on CHA₂DS₂-VASc score

Step 3: Critical Pitfall - Avoid AV Nodal Blocking Agents

DO NOT administer beta-blockers, calcium channel blockers, digoxin, or amiodarone before determining the mechanism 1, 3:

• If pre-excitation/accessory pathway is present, these agents are Class III: Harm 1
• They can paradoxically increase ventricular rate through the accessory pathway
• Risk of precipitating ventricular fibrillation and sudden death
• The ST-deviation may indicate pre-excited conduction

Step 4: Post-Cardioversion Assessment

After successful cardioversion:

1. Obtain 12-lead ECG immediately to assess for:

   • Delta waves (pre-excitation/WPW syndrome)
   • Persistent ST changes (true STEMI vs. rate-related changes)
   • Degree of AV block in sinus rhythm

2. If ST-elevation persists: Proceed to emergent cardiac catheterization for STEMI protocol 2

3. If pre-excitation identified:

   • Avoid all AV nodal blocking agents
   • Procainamide is the drug of choice if arrhythmia recurs 4, 5
   • Arrange urgent electrophysiology study and accessory pathway ablation

4. If complete heart block persists in sinus rhythm:

   • Place temporary transvenous pacemaker
   • Arrange permanent pacemaker implantation per standard heart block guidelines 6

Alternative Scenario: If Pre-Excitation is Confirmed

If the ECG clearly shows pre-excitation (delta waves) with atrial flutter:

Intravenous procainamide or ibutilide are the only acceptable pharmacologic options 4:

• These slow conduction through the accessory pathway
• May terminate the arrhythmia
• Still inferior to immediate cardioversion in this unstable presentation

Post-Acute Management

After stabilization:

1. Cardiac MRI or endomyocardial biopsy if etiology unclear (especially post-COVID or myocarditis) 6
2. Electrophysiology study to define mechanism and guide definitive therapy
3. Catheter ablation of cavotricuspid isthmus for typical flutter or accessory pathway if present 7
4. Close follow-up given high risk of AF development (22-82% over 14 months to 5 years) 7

Key Clinical Pearls

• Electrical cardioversion is both diagnostic and therapeutic in this scenario
• The paradox of RVR with complete heart block suggests either variable block, accessory pathway, or acute ischemic injury
• Time is myocardium—do not delay cardioversion for rate control attempts
• Post-cardioversion rhythm will clarify the underlying conduction abnormality
• This presentation warrants cardiology consultation and likely electrophysiology evaluation regardless of initial response 6